speb/financial-data huggingface dataset:
BAFN balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 36291000.00
BAFN income_statement (annual, 2024-12-31) — Other Special Charges: -11649000.00
BAFN balance_sheet (annual, 2024-12-31) — Payables: 1036000.00
BAFN balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 1036000.00
BAFN balance_sheet (annual, 2024-12-31) — Preferred Stock: 15730000.00
BAFN cash_flow (annual, 2024-12-31) — Preferred Stock Dividend Paid: -1541000.00
BAFN income_statement (annual, 2024-12-31) — Preferred Stock Dividends: 1541000.00
BAFN balance_sheet (annual, 2024-12-31) — Preferred Stock Equity: 15730000.00
BAFN cash_flow (annual, 2024-12-31) — Preferred Stock Issuance: 0.00
BAFN cash_flow (quarterly, 2024-12-31) — Preferred Stock Issuance: 0.00
BAFN income_statement (annual, 2024-12-31) — Pretax Income: 16987000.00
BAFN cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 53000.00
BAFN cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: 97000.00
BAFN income_statement (annual, 2024-12-31) — Professional Expense And Contract Services Expense: 3882000.00
BAFN cash_flow (annual, 2024-12-31) — Purchase Of Investment: -4458000.00
BAFN cash_flow (annual, 2024-12-31) — Purchase Of PPE: -1690000.00
BAFN balance_sheet (annual, 2024-12-31) — Receivables: 9155000.00
BAFN income_statement (annual, 2024-12-31) — Reconciled Depreciation: 8722000.00
BAFN cash_flow (annual, 2024-12-31) — Repayment Of Debt: -10455000.00
BAFN cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -23000.00
BAFN income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
BAFN balance_sheet (annual, 2024-12-31) — Retained Earnings: 44134000.00
BAFN income_statement (annual, 2024-12-31) — Salaries And Wages: 37694000.00
BAFN cash_flow (annual, 2024-12-31) — Sale Of Investment: 7909000.00
BAFN cash_flow (annual, 2024-12-31) — Sale Of PPE: 14746000.00
BAFN income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 2050000.00
BAFN income_statement (annual, 2024-12-31) — Selling General And Administration: 39744000.00
BAFN balance_sheet (annual, 2024-12-31) — Share Issued: 5401526.00
BAFN cash_flow (annual, 2024-12-31) — Short Term Debt Payments: -10000000.00
BAFN cash_flow (quarterly, 2024-12-31) — Short Term Debt Payments: -10000000.00
BAFN income_statement (annual, 2024-12-31) — Special Income Charges: 11649000.00
BAFN cash_flow (annual, 2024-12-31) — Stock Based Compensation: 419000.00
BAFN balance_sheet (annual, 2024-12-31) — Stockholders Equity: 110920000.00
BAFN balance_sheet (annual, 2024-12-31) — Tangible Book Value: 78656000.00
BAFN income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 2958846.00
BAFN income_statement (annual, 2024-12-31) — Tax Provision: 4315000.00
BAFN income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.25
BAFN balance_sheet (annual, 2024-12-31) — Total Assets: 1288297000.00
BAFN balance_sheet (annual, 2024-12-31) — Total Capitalization: 118810000.00
BAFN balance_sheet (annual, 2024-12-31) — Total Debt: 22400000.00
BAFN balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 110920000.00
BAFN balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 1177377000.00
BAFN income_statement (annual, 2024-12-31) — Total Unusual Items: 11649000.00
BAFN income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 11649000.00
BAFN income_statement (quarterly, 2025-03-31) — +Total Revenue: 18715000.00
BAFN balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 1053000.00
BAFN balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 9153000.00
BAFN cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 1726000.00
BAFN cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 1726000.00
BAFN cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 0.00
BAFN balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 29941000.00
BAFN income_statement (quarterly, 2025-03-31) — Average Dilution Earnings: 0.00
BAFN income_statement (quarterly, 2025-03-31) — Basic Average Shares: 5535236.00
BAFN income_statement (quarterly, 2025-03-31) — Basic EPS: -0.13
BAFN cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 77788000.00
BAFN cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -73000.00
BAFN balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 14102000.00
BAFN balance_sheet (quarterly, 2025-03-31) — Capital Stock: 70387000.00
BAFN balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 65179000.00
BAFN balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Federal Funds Sold: 70659000.00
BAFN cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -717000.00
BAFN balance_sheet (quarterly, 2025-03-31) — Cash Financial: 6517000.00
BAFN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 3867000.00
BAFN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -92665000.00
BAFN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 74164000.00
BAFN cash_flow (quarterly, 2025-03-31) — Cash From Discontinued Operating Activities: 0.00
BAFN cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 17000.00
BAFN cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -359000.00
BAFN cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -892000.00
BAFN cash_flow (quarterly, 2025-03-31) — Change In Payable: 17000.00
BAFN cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 17000.00
BAFN cash_flow (quarterly, 2025-03-31) — Change In Receivables: 2000.00
BAFN cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -1232000.00
BAFN cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 2000.00
BAFN cash_flow (quarterly, 2025-03-31) — Changes In Cash: -14634000.00
BAFN balance_sheet (quarterly, 2025-03-31) — Common Stock: 54657000.00
BAFN cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -332000.00
BAFN balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 94355000.00
BAFN cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -340000.00
BAFN cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -189000.00
BAFN cash_flow (quarterly, 2025-03-31) — Deferred Tax: -189000.00
BAFN cash_flow (quarterly, 2025-03-31) — Depreciation: 553000.00
BAFN cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 2279000.00
BAFN cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 2279000.00
BAFN income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 5535236.00
BAFN income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.13
BAFN income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -720000.00
BAFN cash_flow (quarterly, 2025-03-31) — End Cash Position: 63154000.00
BAFN cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 3867000.00
BAFN cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 74091000.00
BAFN cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: 0.00
BAFN balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -2378000.00
BAFN income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 9005000.00
BAFN balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 16460000.00
BAFN balance_sheet (quarterly, 2025-03-31) — Gross PPE: 48253000.00
BAFN balance_sheet (quarterly, 2025-03-31) — Held To Maturity Securities: 2488000.00
BAFN cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 0.00
BAFN income_statement (quarterly, 2025-03-31) — Insurance And Claims: 143000.00
BAFN income_statement (quarterly, 2025-03-31) — Interest Expense: 9686000.00
BAFN income_statement (quarterly, 2025-03-31) — Interest Income: 20685000.00
BAFN cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 9669000.00
BAFN balance_sheet (quarterly, 2025-03-31) — Invested Capital: 122132000.00
BAFN cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -92665000.00
BAFN balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 38806000.00
BAFN cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 20000000.00
BAFN balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 14102000.00
BAFN balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 27777000.00
BAFN balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 41879000.00
BAFN cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -114000.00
BAFN cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -340000.00
BAFN income_statement (quarterly, 2025-03-31) — Net Income: -335000.00
BAFN income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -720000.00
BAFN income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -335000.00
BAFN income_statement (quarterly, 2025-03-31) — Net Income Discontinuous Operations: 0.00
BAFN income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -335000.00
BAFN income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -335000.00
BAFN cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -335000.00
BAFN income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -335000.00
BAFN income_statement (quarterly, 2025-03-31) — Net Interest Income: 10999000.00
BAFN cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -201000.00
BAFN cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 19886000.00
BAFN cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -114000.00
BAFN balance_sheet (quarterly, 2025-03-31) — Net PPE: 48253000.00
BAFN cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -73000.00
BAFN cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: 20000000.00
BAFN balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 93625000.00
BAFN balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 648000.00
BAFN balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 648000.00
BAFN income_statement (quarterly, 2025-03-31) — Normalized Income: -335000.00
BAFN income_statement (quarterly, 2025-03-31) — Occupancy And Equipment: 1634000.00
BAFN cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 74164000.00
BAFN cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -6572000.00
BAFN income_statement (quarterly, 2025-03-31) — Operating Revenue: 18715000.00
BAFN balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 5396352.00
BAFN balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -2378000.00
BAFN balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: -1006000.00
BAFN balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 16460000.00
BAFN cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 76375000.00
BAFN income_statement (quarterly, 2025-03-31) — Other Non Interest Expense: 2920000.00
BAFN balance_sheet (quarterly, 2025-03-31) — Other Properties: 48253000.00
BAFN balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 6377000.00
BAFN balance_sheet (quarterly, 2025-03-31) — Payables: 1053000.00
BAFN balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 1053000.00
BAFN balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 15730000.00
BAFN cash_flow (quarterly, 2025-03-31) — Preferred Stock Dividend Paid: -385000.00
BAFN income_statement (quarterly, 2025-03-31) — Preferred Stock Dividends: 385000.00
BAFN balance_sheet (quarterly, 2025-03-31) — Preferred Stock Equity: 15730000.00
BAFN income_statement (quarterly, 2025-03-31) — Pretax Income: -463000.00
BAFN cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 0.00
BAFN income_statement (quarterly, 2025-03-31) — Professional Expense And Contract Services Expense: 732000.00
BAFN cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -3434000.00
BAFN cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -73000.00
BAFN balance_sheet (quarterly, 2025-03-31) — Receivables: 9153000.00
BAFN income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 2279000.00
BAFN cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -114000.00
BAFN cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -340000.00
BAFN balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 43082000.00
BAFN income_statement (quarterly, 2025-03-31) — Salaries And Wages: 8862000.00
BAFN cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 3233000.00
BAFN income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 487000.00
BAFN income_statement (quarterly, 2025-03-31) — Selling General And Administration: 9492000.00
BAFN balance_sheet (quarterly, 2025-03-31) — Share Issued: 5396352.00
BAFN cash_flow (quarterly, 2025-03-31) — Short Term Debt Issuance: 20000000.00
BAFN income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
BAFN cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: -21000.00
BAFN balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 110085000.00
BAFN balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 77895000.00
BAFN income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
BAFN income_statement (quarterly, 2025-03-31) — Tax Provision: -128000.00
BAFN income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.28
BAFN balance_sheet (quarterly, 2025-03-31) — Total Assets: 1291957000.00
BAFN balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 137862000.00
BAFN balance_sheet (quarterly, 2025-03-31) — Total Debt: 41879000.00
BAFN balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 110085000.00
BAFN balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 1181872000.00
BAFN income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
BAFN income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
BAFN income_statement (quarterly, 2025-06-30) — +Total Revenue: 20585000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1148000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 9495000.00
BAFN cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 1949000.00
BAFN cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 1949000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 32938000.00
BAFN income_statement (quarterly, 2025-06-30) — Basic Average Shares: 5438842.00
BAFN income_statement (quarterly, 2025-06-30) — Basic EPS: -0.30
BAFN cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 63154000.00
BAFN cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -193000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 13819000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Capital Stock: 70469000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 78579000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Federal Funds Sold: 78579000.00
BAFN cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -717000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Cash Financial: 6142000.00
BAFN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 54695000.00
BAFN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -103843000.00
BAFN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 63293000.00
BAFN cash_flow (quarterly, 2025-06-30) — Cash From Discontinued Operating Activities: 0.00
BAFN cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 95000.00
BAFN cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -2811000.00
BAFN cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -1928000.00
BAFN cash_flow (quarterly, 2025-06-30) — Change In Payable: 95000.00
BAFN cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 95000.00
BAFN cash_flow (quarterly, 2025-06-30) — Change In Receivables: -342000.00
BAFN cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -4986000.00
BAFN cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -342000.00
BAFN cash_flow (quarterly, 2025-06-30) — Changes In Cash: 14145000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Common Stock: 54739000.00
BAFN cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -331000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 92493000.00
BAFN cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -4000.00
BAFN cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 0.00
BAFN cash_flow (quarterly, 2025-06-30) — Deferred Tax: 0.00
BAFN cash_flow (quarterly, 2025-06-30) — Depreciation: 555000.00
BAFN cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 2504000.00
BAFN cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 2504000.00
BAFN income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 5438842.00
BAFN income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.30
BAFN income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -1623000.00
BAFN cash_flow (quarterly, 2025-06-30) — End Cash Position: 77299000.00
BAFN cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 54695000.00
BAFN cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 63100000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -2368000.00
BAFN income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 8837000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 16074000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Gross PPE: 47567000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Held To Maturity Securities: 2491000.00
BAFN cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 5296000.00
BAFN income_statement (quarterly, 2025-06-30) — Interest Expense: 10157000.00
BAFN income_statement (quarterly, 2025-06-30) — Interest Income: 22505000.00
BAFN cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 10062000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Invested Capital: 140159000.00
BAFN cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -103843000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 39298000.00
BAFN cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 20000000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 13819000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 47666000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 61485000.00
BAFN cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -113000.00
BAFN cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -4000.00
BAFN income_statement (quarterly, 2025-06-30) — Net Income: -1237000.00
BAFN income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -1623000.00
BAFN income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -1237000.00
BAFN income_statement (quarterly, 2025-06-30) — Net Income Discontinuous Operations: 0.00
BAFN income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -1237000.00
BAFN income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -1237000.00
BAFN cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -1237000.00
BAFN income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -1237000.00
BAFN income_statement (quarterly, 2025-06-30) — Net Interest Income: 12348000.00
BAFN cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 5013000.00
BAFN cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 19887000.00
BAFN cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -113000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Net PPE: 47567000.00
BAFN cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -193000.00
BAFN cash_flow (quarterly, 2025-06-30) — Net Short Term Debt Issuance: 20000000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 92149000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 895000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 895000.00
BAFN income_statement (quarterly, 2025-06-30) — Normalized Income: -1237000.00
BAFN income_statement (quarterly, 2025-06-30) — Occupancy And Equipment: 1579000.00
BAFN cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 63293000.00
BAFN cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -8992000.00
BAFN income_statement (quarterly, 2025-06-30) — Operating Revenue: 20585000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 5403017.00
BAFN balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -2368000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: -1006000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 16074000.00
BAFN cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 69590000.00
BAFN income_statement (quarterly, 2025-06-30) — Other Non Interest Expense: 3369000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Other Properties: 47567000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 3869000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Payables: 1148000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 1148000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 15730000.00
BAFN cash_flow (quarterly, 2025-06-30) — Preferred Stock Dividend Paid: -386000.00
BAFN income_statement (quarterly, 2025-06-30) — Preferred Stock Dividends: 386000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Preferred Stock Equity: 15730000.00
BAFN income_statement (quarterly, 2025-06-30) — Pretax Income: -1649000.00
BAFN cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 0.00
BAFN income_statement (quarterly, 2025-06-30) — Professional Expense And Contract Services Expense: 782000.00
BAFN cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -4309000.00
BAFN cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -193000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Receivables: 9495000.00
BAFN income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 2504000.00
BAFN cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -113000.00
BAFN cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -4000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 41128000.00
BAFN income_statement (quarterly, 2025-06-30) — Salaries And Wages: 8837000.00
BAFN cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 9322000.00
BAFN income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 403000.00
BAFN income_statement (quarterly, 2025-06-30) — Selling General And Administration: 9240000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Share Issued: 5403017.00
BAFN cash_flow (quarterly, 2025-06-30) — Short Term Debt Issuance: 20000000.00
BAFN cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 77000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 108223000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 76419000.00
BAFN income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
BAFN income_statement (quarterly, 2025-06-30) — Tax Provision: -412000.00
BAFN income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.25
BAFN balance_sheet (quarterly, 2025-06-30) — Total Assets: 1343867000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 155889000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Total Debt: 61485000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 108223000.00
BAFN balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 1235644000.00
BAFN income_statement (quarterly, 2025-09-30) — +Total Revenue: 6961000.00
BAFN balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 1082000.00
BAFN balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 8898000.00
BAFN cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 1685000.00
BAFN cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 1685000.00
BAFN balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 25976000.00
BAFN income_statement (quarterly, 2025-09-30) — Average Dilution Earnings: 0.00
BAFN income_statement (quarterly, 2025-09-30) — Basic Average Shares: 5409179.00
BAFN income_statement (quarterly, 2025-09-30) — Basic EPS: -3.57
BAFN cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 77299000.00
BAFN cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -10000.00
BAFN balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 13554000.00
BAFN balance_sheet (quarterly, 2025-09-30) — Capital Stock: 70494000.00
BAFN balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 119834000.00
BAFN balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Federal Funds Sold: 126862000.00
BAFN cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: 0.00
BAFN balance_sheet (quarterly, 2025-09-30) — Cash Financial: 5193000.00
BAFN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 17949000.00
BAFN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -24005000.00
BAFN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 47307000.00
BAFN cash_flow (quarterly, 2025-09-30) — Cash From Discontinued Operating Activities: 184764000.00
BAFN cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -66000.00
BAFN cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -5037000.00
BAFN cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 3456000.00
BAFN cash_flow (quarterly, 2025-09-30) — Change In Payable: -66000.00
BAFN cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -66000.00
BAFN cash_flow (quarterly, 2025-09-30) — Change In Receivables: 597000.00
BAFN cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -1050000.00
BAFN cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: 597000.00
BAFN cash_flow (quarterly, 2025-09-30) — Changes In Cash: 41251000.00
BAFN balance_sheet (quarterly, 2025-09-30) — Common Stock: 54764000.00
BAFN cash_flow (quarterly, 2025-09-30) — Common Stock Dividend Paid: 0.00
BAFN balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 73998000.00
BAFN cash_flow (quarterly, 2025-09-30) — Common Stock Payments: 9000.00
BAFN cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 0.00
BAFN cash_flow (quarterly, 2025-09-30) — Deferred Tax: 0.00
BAFN cash_flow (quarterly, 2025-09-30) — Depreciation: 549000.00
BAFN cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 2234000.00
BAFN cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 2234000.00
BAFN income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 5409179.00
BAFN income_statement (quarterly, 2025-09-30) — Diluted EPS: -3.57
BAFN income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -19287000.00
BAFN cash_flow (quarterly, 2025-09-30) — End Cash Position: 118550000.00
BAFN cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 17949000.00
BAFN cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 47297000.00
BAFN balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -2069000.00
BAFN income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 8531000.00
BAFN balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 15663000.00
BAFN balance_sheet (quarterly, 2025-09-30) — Gross PPE: 46528000.00
BAFN balance_sheet (quarterly, 2025-09-30) — Held To Maturity Securities: 2491000.00
BAFN cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 0.00
BAFN income_statement (quarterly, 2025-09-30) — Interest Expense: 10374000.00
BAFN income_statement (quarterly, 2025-09-30) — Interest Income: 21654000.00
BAFN cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 10440000.00
BAFN balance_sheet (quarterly, 2025-09-30) — Invested Capital: 131552000.00
BAFN cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -24005000.00
BAFN balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 32348000.00
BAFN cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 10000000.00
BAFN balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 13554000.00
BAFN balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 57554000.00
BAFN balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 71108000.00
BAFN cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -114000.00
BAFN cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 34000.00
BAFN income_statement (quarterly, 2025-09-30) — Net Income: -18902000.00
BAFN income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -19287000.00
BAFN income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -18902000.00
BAFN income_statement (quarterly, 2025-09-30) — Net Income Discontinuous Operations: 0.00
BAFN income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -18902000.00
BAFN income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -18902000.00
BAFN cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -18902000.00
BAFN income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -18902000.00
BAFN income_statement (quarterly, 2025-09-30) — Net Interest Income: 11280000.00
BAFN cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 317000.00
BAFN cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 9886000.00
BAFN cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -114000.00
BAFN cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 32000.00
BAFN balance_sheet (quarterly, 2025-09-30) — Net PPE: 46528000.00
BAFN cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -10000.00
BAFN cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: 10000000.00
BAFN balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 74065000.00
BAFN income_statement (quarterly, 2025-09-30) — Normalized Income: -13601323.29
BAFN income_statement (quarterly, 2025-09-30) — Occupancy And Equipment: 1525000.00
BAFN cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 47307000.00
BAFN cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 2915000.00
BAFN income_statement (quarterly, 2025-09-30) — Operating Revenue: 6961000.00
BAFN balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 5380519.00
BAFN balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -2069000.00
BAFN balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: -538000.00
BAFN balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 15663000.00
BAFN cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -134537000.00
BAFN income_statement (quarterly, 2025-09-30) — Other Non Interest Expense: 3503000.00
BAFN balance_sheet (quarterly, 2025-09-30) — Other Properties: 46528000.00
BAFN balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 3881000.00
BAFN balance_sheet (quarterly, 2025-09-30) — Payables: 1082000.00
BAFN balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 1082000.00
BAFN balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 15730000.00
BAFN cash_flow (quarterly, 2025-09-30) — Preferred Stock Dividend Paid: 0.00
BAFN income_statement (quarterly, 2025-09-30) — Preferred Stock Dividends: 385000.00
BAFN balance_sheet (quarterly, 2025-09-30) — Preferred Stock Equity: 15730000.00
BAFN income_statement (quarterly, 2025-09-30) — Pretax Income: -25896000.00
BAFN cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 368000.00
BAFN income_statement (quarterly, 2025-09-30) — Professional Expense And Contract Services Expense: 859000.00
BAFN cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -477000.00
BAFN cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -10000.00
BAFN balance_sheet (quarterly, 2025-09-30) — Receivables: 8898000.00
BAFN income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 2234000.00
BAFN cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -114000.00
BAFN cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: 9000.00
BAFN income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 7262000.00
BAFN balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 21841000.00
BAFN income_statement (quarterly, 2025-09-30) — Salaries And Wages: 8531000.00
BAFN cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 794000.00
BAFN income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 262000.00
BAFN income_statement (quarterly, 2025-09-30) — Selling General And Administration: 8793000.00
BAFN balance_sheet (quarterly, 2025-09-30) — Share Issued: 5380519.00
BAFN cash_flow (quarterly, 2025-09-30) — Short Term Debt Issuance: 10000000.00
BAFN income_statement (quarterly, 2025-09-30) — Special Income Charges: -7262000.00
BAFN cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 100000.00
BAFN balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 89728000.00
BAFN balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 58335000.00
BAFN income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -1961323.29
BAFN income_statement (quarterly, 2025-09-30) — Tax Provision: -6994000.00
BAFN income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.27
BAFN balance_sheet (quarterly, 2025-09-30) — Total Assets: 1345978000.00
BAFN balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 147282000.00
BAFN balance_sheet (quarterly, 2025-09-30) — Total Debt: 71108000.00
BAFN balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 89728000.00
BAFN balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1256250000.00
BAFN income_statement (quarterly, 2025-09-30) — Total Unusual Items: -7262000.00
BAFN income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -7262000.00
BAFN income_statement (annual, 2025-12-31) — +Total Revenue: 56180000.00
BAFN income_statement (quarterly, 2025-12-31) — +Total Revenue: 9919000.00
BAFN balance_sheet (annual, 2025-12-31) — Accounts Payable: 1133000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 1133000.00
BAFN balance_sheet (annual, 2025-12-31) — Accounts Receivable: 8421000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 8421000.00
BAFN balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -10608000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -10608000.00
BAFN cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 6928000.00
BAFN cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 1568000.00
BAFN cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 6928000.00
BAFN cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 1568000.00
BAFN cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 1422000.00
BAFN cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 0.00
BAFN balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 29363000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 29363000.00
BAFN income_statement (annual, 2025-12-31) — Average Dilution Earnings: 0.00
BAFN income_statement (quarterly, 2025-12-31) — Average Dilution Earnings: 0.00
BAFN income_statement (annual, 2025-12-31) — Basic Average Shares: 5394781.00
BAFN income_statement (quarterly, 2025-12-31) — Basic Average Shares: 5394404.00
BAFN income_statement (annual, 2025-12-31) — Basic EPS: -4.54
BAFN income_statement (quarterly, 2025-12-31) — Basic EPS: -0.53
BAFN cash_flow (annual, 2025-12-31) — Beginning Cash Position: 77788000.00
BAFN cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 118550000.00
BAFN balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 25146000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 25146000.00
BAFN cash_flow (annual, 2025-12-31) — Capital Expenditure: -300000.00
BAFN cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -24000.00
BAFN balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 13264000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 13264000.00
BAFN balance_sheet (annual, 2025-12-31) — Capital Stock: 70101000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Capital Stock: 70101000.00
BAFN balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 206982000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 206982000.00
BAFN balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 211638000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 211638000.00
BAFN cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -1434000.00
BAFN cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: 0.00
BAFN balance_sheet (annual, 2025-12-31) — Cash Financial: 5123000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Cash Financial: 5123000.00
BAFN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 38842000.00
BAFN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -37669000.00
BAFN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -194943000.00
BAFN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 25570000.00
BAFN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 285295000.00
BAFN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 100531000.00
BAFN cash_flow (annual, 2025-12-31) — Cash From Discontinued Operating Activities: 0.00
BAFN cash_flow (quarterly, 2025-12-31) — Cash From Discontinued Operating Activities: -184764000.00
BAFN cash_flow (annual, 2025-12-31) — Change In Account Payable: 97000.00
BAFN cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 51000.00
BAFN cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -1174000.00
BAFN cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 7033000.00
BAFN cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -5013000.00
BAFN cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -5649000.00
BAFN cash_flow (annual, 2025-12-31) — Change In Payable: 97000.00
BAFN cash_flow (quarterly, 2025-12-31) — Change In Payable: 51000.00
BAFN cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 97000.00
BAFN cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 51000.00
BAFN cash_flow (annual, 2025-12-31) — Change In Receivables: 734000.00
BAFN cash_flow (quarterly, 2025-12-31) — Change In Receivables: 477000.00
BAFN cash_flow (annual, 2025-12-31) — Change In Working Capital: -5356000.00
BAFN cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 1912000.00
BAFN cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 734000.00
BAFN cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 477000.00
BAFN cash_flow (annual, 2025-12-31) — Changes In Cash: 129194000.00
BAFN cash_flow (quarterly, 2025-12-31) — Changes In Cash: 88432000.00
BAFN balance_sheet (annual, 2025-12-31) — Common Stock: 54371000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Common Stock: 54371000.00
BAFN cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -663000.00
BAFN cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: 0.00
BAFN balance_sheet (annual, 2025-12-31) — Common Stock Equity: 71839000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 71839000.00
BAFN cash_flow (annual, 2025-12-31) — Common Stock Issuance: 50000.00
BAFN cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 25000.00
BAFN cash_flow (annual, 2025-12-31) — Common Stock Payments: -335000.00
BAFN cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 0.00
BAFN balance_sheet (annual, 2025-12-31) — Construction In Progress: 0.00
BAFN balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 0.00
BAFN cash_flow (annual, 2025-12-31) — Deferred Income Tax: -7221000.00
BAFN cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -7032000.00
BAFN cash_flow (annual, 2025-12-31) — Deferred Tax: -7221000.00
BAFN cash_flow (quarterly, 2025-12-31) — Deferred Tax: -7032000.00
BAFN cash_flow (annual, 2025-12-31) — Depreciation: 2188000.00
BAFN cash_flow (quarterly, 2025-12-31) — Depreciation: 531000.00
BAFN cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 9116000.00
BAFN cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 2099000.00
BAFN cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 9116000.00
BAFN cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 2099000.00
BAFN income_statement (annual, 2025-12-31) — Diluted Average Shares: 5394781.00
BAFN income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 5394404.00
BAFN income_statement (annual, 2025-12-31) — Diluted EPS: -4.54
BAFN income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.53
BAFN income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -24478000.00
BAFN income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -2848000.00
BAFN cash_flow (annual, 2025-12-31) — End Cash Position: 206982000.00
BAFN cash_flow (quarterly, 2025-12-31) — End Cash Position: 206982000.00
BAFN cash_flow (annual, 2025-12-31) — Financing Cash Flow: 38842000.00
BAFN cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -37669000.00
BAFN cash_flow (annual, 2025-12-31) — Free Cash Flow: 284995000.00
BAFN cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 100507000.00
BAFN cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 0.00
BAFN balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -1960000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -1960000.00
BAFN income_statement (annual, 2025-12-31) — General And Administrative Expense: 30937000.00
BAFN income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 4883000.00
BAFN balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 12580000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 12580000.00
BAFN balance_sheet (annual, 2025-12-31) — Gross PPE: 56300000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Gross PPE: 56300000.00
BAFN balance_sheet (annual, 2025-12-31) — Held To Maturity Securities: 2493000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Held To Maturity Securities: 2493000.00
BAFN cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 5296000.00
BAFN cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 0.00
BAFN income_statement (annual, 2025-12-31) — Interest Expense: 40009000.00
BAFN income_statement (quarterly, 2025-12-31) — Interest Expense: 9792000.00
BAFN income_statement (annual, 2025-12-31) — Interest Income: 85794000.00
BAFN income_statement (quarterly, 2025-12-31) — Interest Income: 20950000.00
BAFN cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 39912000.00
BAFN cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 9741000.00
BAFN balance_sheet (annual, 2025-12-31) — Invested Capital: 79394000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Invested Capital: 79394000.00
BAFN cash_flow (annual, 2025-12-31) — Investing Cash Flow: -194943000.00
BAFN cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 25570000.00
BAFN balance_sheet (annual, 2025-12-31) — Investments And Advances: 31856000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 31856000.00
BAFN cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 50000.00
BAFN cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 25000.00
BAFN balance_sheet (annual, 2025-12-31) — Land And Improvements: 5530000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 5530000.00
BAFN balance_sheet (annual, 2025-12-31) — Leases: 3092000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Leases: 3092000.00
BAFN balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 13264000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 13264000.00
BAFN balance_sheet (annual, 2025-12-31) — Long Term Debt: 7555000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 7555000.00
BAFN balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 20819000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 20819000.00
BAFN cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -341000.00
BAFN cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: 0.00
BAFN balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 8028000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 8028000.00
BAFN cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -285000.00
BAFN cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 25000.00
BAFN income_statement (annual, 2025-12-31) — Net Income: -22937000.00
BAFN income_statement (quarterly, 2025-12-31) — Net Income: -2463000.00
BAFN income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -24478000.00
BAFN income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -2848000.00
BAFN income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -22937000.00
BAFN income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -2463000.00
BAFN income_statement (annual, 2025-12-31) — Net Income Discontinuous Operations: 0.00
BAFN income_statement (quarterly, 2025-12-31) — Net Income Discontinuous Operations: 0.00
BAFN income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -22937000.00
BAFN income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -2463000.00
BAFN income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -22937000.00
BAFN income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -2463000.00
BAFN cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -22937000.00
BAFN cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -2463000.00
BAFN income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -22937000.00
BAFN income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -2463000.00
BAFN income_statement (annual, 2025-12-31) — Net Interest Income: 45785000.00
BAFN income_statement (quarterly, 2025-12-31) — Net Interest Income: 11158000.00
BAFN cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 8135000.00
BAFN cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 3006000.00
BAFN cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -341000.00
BAFN cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -50000000.00
BAFN cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -341000.00
BAFN cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 0.00
BAFN cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 214000.00
BAFN cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 0.00
BAFN balance_sheet (annual, 2025-12-31) — Net PPE: 45692000.00
BAFN balance_sheet (quarterly, 2025-12-31) — Net PPE: 45692000.00
BAFN cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -300000.00